Table 1.
Psychotropic drugs and FDA labeled psychiatric uses in youth.*
| Class, Subclass | Drug | Age Limits, yr. | Indication |
| Stimulants | |||
| Amphetamines | 3+ | ADHD; Narcolepsy | |
| Methylphenidate | 6+ | ADHD; Narcolepsy | |
| Modafinil | 16+ | Narcolepsy | |
| Antidepressants | |||
| SSRI | |||
| Fluoxetine | 8+ | Depression | |
| 7+ | OCD | ||
| Fluvoxamine | 8+ | OCD | |
| Sertraline | 6+ | OCD | |
| TCA | |||
| Clomipramine | 10+ | OCD | |
| Doxepin | 12+ | Depression | |
| Impiramine | 6+ | Enuresis | |
| 12+ | Depression | ||
| Antipsychotics | |||
| Conventional | |||
| Chlorpromazine | 6 (mo)-12 | Severe Behavior Problems; Psychosis | |
| Haloperidol | 3+ | Tourette's Disorder; Psychosis; Severe Behavioral Disorders | |
| Thiothixene | 12+ | Psychosis | |
| Loxapine | 16+ | Psychosis | |
| Molindone | 12+ | Psychosis | |
| Fluphenazine | 12+ | Psychosis | |
| Trifluperazine | 12+ | Psychosis | |
| Perphenazine | 12+ | Schizophrenia | |
| Pimozide | 12+ | Tourette's Disorder | |
| Prochlorperazine | 2–12 | Psychosis | |
| Thioridazine | 2+ | Schizophrenia | |
| Atypical | |||
| Aripiprazole | 13+ | Schizophrenia | |
| 10+ | Acute and Mixed Mania | ||
| Risperidone | 10+ | Acute and Mixed Mania; | |
| 5–16 | Irritability in Autism | ||
| 13+ | Schizophrenia | ||
| Miscellaneous | |||
| Atomoxetine | 6+ | ADHD | |
| Chlordiazepoxide | 6+ | Anxiety | |
| Clorazepate | 10+ | Anxiety | |
| Desmopressin Oral | 6+ | Enuresis | |
| Diazepam | 6 months + | Anxiety | |
| Flurazepam | 15+ | Insomnia | |
| Hydroxyzine | < 6 | Anxiety | |
| > 6 | Sedation | ||
| Lithium Carbonate | 12+ | Manic Episodes | |
| Promethazine | 2+ | Sedation |
*This information was current on March 12, 2008 based on the Physicians Desk Reference 2007 or FDA announcements. Readers should consult FDA guidelines for most current drug labeling.